Febuxostat
- Product NDC
- 14445-157
- 11-digit product format
- 144450157
- Labeler code
- 14445
- Product ID
- 14445-157_60d6e78a-98f8-4968-ad5f-37689cc2c096
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Febuxostat
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Indoco Remedies Limited
- Application
- ANDA210292
- Marketing category
- ANDA
- Marketing start
- 2017-02-15
- Marketing end
- 0000-00-00
- Substance
- FEBUXOSTAT
- Active strength
- 80 mg/1
- Pharmacologic classes
- Xanthine Oxidase Inhibitor [EPC],Xanthine Oxidase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 14445-157-00 | Febuxostat | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | | 7 |
| 14445-157-01 | Febuxostat | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | | 7 |
| 14445-157-30 | Febuxostat | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 14445-157 | FEBUXOSTAT TABLET, FILM COATED [INDOCO REMEDIES LIMITED ] | 7 | Legacy NDC, 3 package rows | 20200113_39ee3ba8-af0d-4273-8c2e-552ba19084a4.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 14445-157-00 | 14445015700 | 1000 TABLET, FILM COATED in 1 BOTTLE (14445-157-00) | 2017-02-15 | 0000-00-00 | No | No | Current |
| 14445-157-01 | 14445015701 | 100 TABLET, FILM COATED in 1 BOTTLE (14445-157-01) | 2017-02-15 | 0000-00-00 | No | No | Current |
| 14445-157-30 | 14445015730 | 30 TABLET, FILM COATED in 1 BOTTLE (14445-157-30) | 2017-02-15 | 0000-00-00 | No | No | Current |